Literature DB >> 31605893

Serum lactate levels are associated with glioma malignancy grade.

Mariana Branco1, Paulo Linhares2, Bruno Carvalho3, Patrícia Santos4, Bruno M Costa5, Rui Vaz2.   

Abstract

OBJECTIVE: Recent studies have suggested that high grade gliomas are associated with elevated serum lactate concentrations. The aim of the present study is to assess these findings in a sample of patients. PATIENTS AND METHODS: We reviewed the anesthetic charts of patients with low-grade and high-grade glioma who underwent resection surgery and collected serum lactate concentration before tumor resection, as well as other demographic and tumor-related data (age, gender, WHO grade, and size of the tumor). A statistical comparison between patients with normal (<2 mmol/L) and elevated (≥ 2 mmol/L) serum lactate was performed.
RESULTS: We included a total of 152 patients (mean age 49.07 years). 62.5% of patients (n = 95) had a high-grade glioma and 37.5% (n = 67) a low-grade glioma. The multivariate regression showed that high grade gliomas had significantly higher lactate concentration (p < 0.01). The OR for elevated pre-resection serum lactate increased from 4.94 to 14.33 after adjusting for age and pre-surgical corticosteroid use, and the AUC for the final regression model was 0.98.
CONCLUSION: This study reinforces the role of serum lactate as a potential biomarker of brain tumors malignancy, and its results encourage further research on this subject, in order to improve the understanding of this phenomenon and to assess its potential as prognostic and therapeutic monitoring tool.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Diagnosis; Glioma; Lactate; Neuro-oncology; Neurosurgery

Year:  2019        PMID: 31605893     DOI: 10.1016/j.clineuro.2019.105546

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

Review 1.  Application of 7T MRS to High-Grade Gliomas.

Authors:  L McCarthy; G Verma; G Hangel; A Neal; B A Moffat; J P Stockmann; O C Andronesi; P Balchandani; C G Hadjipanayis
Journal:  AJNR Am J Neuroradiol       Date:  2022-05-26       Impact factor: 4.966

2.  Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas.

Authors:  Masatomo Maeda; Myat Ko; Mayuresh M Mane; Ivan J Cohen; Masahiro Shindo; Kiranmayi Vemuri; Inna Serganova; Ronald Blasberg
Journal:  Cancers (Basel)       Date:  2022-05-06       Impact factor: 6.575

3.  Elevated Serum Lactate in Glioma Patients: Associated Factors.

Authors:  Beathe Sitter; Annamaria Forsmark; Ole Solheim
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

4.  Lymphoma total lesion glycolysis leads to hyperlactatemia and reduction of brain glucose utilization.

Authors:  Hyun Kyung Yi; Jang Yoo; Seok Jin Kim; Joon Young Choi; Kyung-Han Lee
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

Review 5.  The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma.

Authors:  Anna Maria Reuss; Dominik Groos; Michael Buchfelder; Nicolai Savaskan
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

6.  Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review.

Authors:  Hamza Ali; Romée Harting; Ralph de Vries; Meedie Ali; Thomas Wurdinger; Myron G Best
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

7.  Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin.

Authors:  Shaomeng Chen; Xiuman Zhou; Xin Yang; Wanqiong Li; Shuzhen Li; Zheng Hu; Chen Ling; Ranran Shi; Juan Liu; Guanyu Chen; Nazi Song; Xianxing Jiang; Xinghua Sui; Yanfeng Gao
Journal:  Biomolecules       Date:  2021-09-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.